Genomic Health Inc

GHDX

Sector
Healthcare

Industry
Medical Laboratories & Research




Buy / Sell (dollars)

1 Month

12.9% 12.9% Complete (success)
87.1% 87.1% Complete (danger)
$373,563.52
avg. $373,563.52
$2.521M
avg. $2.521M

Buy/Sell Ratio

0.148

Transactions

21

Filers

4

3 Month

3.4% 3.4% Complete (success)
96.6% 96.6% Complete (danger)
$3.193M
avg. $1.064M
$91.419M
avg. $30.473M

Buy/Sell Ratio

0.035

Transactions

241

Filers

14

12 Month

6.7% 6.7% Complete (success)
93.3% 93.3% Complete (danger)
$16.385M
avg. $1.365M
$227.453M
avg. $18.954M

Buy/Sell Ratio

0.072

Transactions

633

Filers

15

24 Month

8.6% 8.6% Complete (success)
91.4% 91.4% Complete (danger)
$22.014M
avg. $917,254.80
$235.182M
avg. $9.799M

Buy/Sell Ratio

0.094

Transactions

780

Filers

16

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers